# Silo Pharma, Inc.: Form 8-K, filed Mar 10, 2025

- Company: [Silo Pharma, Inc.](/companies/silo.md) (CIK 1514183)
- Form: 8-K
- Filed: 2025-03-10
- Accepted by EDGAR: Mar 10, 2025, 07:31 ET
- Period: 2025-03-10
- Accession: 0001213900-25-021916
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1514183/000121390025021916/ea0233727-8k_silopharma.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1514183/000121390025021916/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1514183/000121390025021916/ea0233727-8k_silopharma.htm

Filed Mar 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-021916. Last ingested by Listed: Nov 14, 2026, 21:25 ET. No prices; not investment advice.
